Beyond Metabolic Health: The Emerging Frontier of Incretin Therapies in Addiction
Emerging evidence suggests GLP-1 receptor agonists may reduce alcohol cravings and heavy drinking, offering a promising new treatment approach for alcohol use disorder, especially with obesity.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.